Skip to content

Awridian Ltd

A Drug Discovery Consultancy

  • Home
  • Services
  • Resources
  • Goals
  • Publications
  • About
  • Compound Library
Posted on 24/01/201924/01/2019 by admin

Up turn: but how good

2018 FDA drug approvals

The FDA approved a record 59 drugs last year (2018), but the commercial potential of these drugs is lacklustre.

Take a look at Asher Mullard’s article

Post navigation

Previous PostPrevious New Web Site
Next PostNext Compound Collection Enhancement strategy: Bayer

Recent Posts

  • March 2025
  • BOS Manchester 2024
  • BMCS Conformational Design in Drug Discovery 2024
  • BOS Manchester 2023
  • SMR RSC RECENT TRENDS IN MEDICINAL CHEMISTRY AND ENABLING TECHNOLOGIES

Recent Comments

    Archives

    • March 2025
    • October 2024
    • March 2024
    • October 2023
    • October 2022
    • July 2022
    • February 2022
    • February 2021
    • January 2021
    • February 2020
    • January 2020
    • October 2019
    • August 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Search Awridian

    News

    • March 2025 17/03/2025
    • BOS Manchester 2024 14/10/2024
    • BMCS Conformational Design in Drug Discovery 2024 04/03/2024
    • BOS Manchester 2023 23/10/2023
    • SMR RSC RECENT TRENDS IN MEDICINAL CHEMISTRY AND ENABLING TECHNOLOGIES 12/10/2022
    Privacy Policy and Cookies Proudly powered by WordPress